Sanofi Creates Consumer Unit With Eye To Expansion

Former Bayer executive Alan Main tapped to lead Consumer HealthCare global business unit, which Sanofi will consider expanding through acquisitions after integrating OTC brands added in a recent swap with Boehringer Ingelheim.

Sanofi has selected pharma industry veteran Alan Main to head the global consumer health unit it will launch once it completes its acquisition of Boehringer Ingelheim GMBH consumer brands and that it will consider expanding with “very detailed” acquisitions.

Main will join Sanofi Oct. 1, with responsibility for building on Sanofi’s position in consumer health, including overseeing the integration...

Welcome to Pink Sheet

Create an account to read this article

More from Agency Leadership

More from Pink Sheet

A Record Year For US FDA Approvals? Commissioner Says It’s Possible

 

FDA Commissioner Martin Makary suggested 60 new molecular entities could be approved in 2025, which appears possible, but can the strained staff deliver?

PharmaMar Withdraws EU Aplidin Filing After Regulatory Rollercoaster

 

PharmaMar has voluntarily withdrawn its marketing authorization application for Aplidin to treat multiple myeloma in the EU – almost a decade after it first filed the drug for EU approval and following years of court proceedings.

Italy To Reward Locally Conducted R&D In Innovative Medicines Fund Revamp

 

Antibiotics that tackle antimicrobial resistance are to be automatically included in Italy’s Innovative Medicines Fund, which is designed to provide quick access to innovative medicines.